These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38098548)

  • 21. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
    JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
    Gurevich I; Agarwal P; Zhang P; Dolorito JA; Oliver S; Liu H; Reitze N; Sarma N; Bagci IS; Sridhar K; Kakarla V; Yenamandra VK; O'Malley M; Prisco M; Tufa SF; Keene DR; South AP; Krishnan SM; Marinkovich MP
    Nat Med; 2022 Apr; 28(4):780-788. PubMed ID: 35347281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of pleural effusion and dilated cardiomyopathy in a case of dystrophic epidermolysis bullosa.
    Arshad MA; Ayub MR; Zil-E-Ali A; Rashid S; Kazi MY; Pervaiz MA
    J Pak Med Assoc; 2020 Jun; 70(6):1106-1109. PubMed ID: 32810122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell- and protein-based therapy approaches for epidermolysis bullosa.
    Nyström A; Bruckner-Tuderman L; Kern JS
    Methods Mol Biol; 2013; 961():425-40. PubMed ID: 23325662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
    Chung HJ; Uitto J
    Dermatol Clin; 2010 Jan; 28(1):93-105. PubMed ID: 19945621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Remington J; Chen M; Burnett J; Woodley DT
    Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
    Gayathri E; Anbukkarasi K; Lilly SM
    Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
    Remington J; Wang X; Hou Y; Zhou H; Burnett J; Muirhead T; Uitto J; Keene DR; Woodley DT; Chen M
    Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies.
    Bornert O; Kocher T; Gretzmeier C; Liemberger B; Hainzl S; Koller U; Nyström A
    Matrix Biol Plus; 2019 Nov; 4():100017. PubMed ID: 33543014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
    Windler C; Hermsdorf U; Brinckmann J; Seeger K
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):52-59. PubMed ID: 27989960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophic epidermolysis bullosa inversa: report of two cases with further correlation between electron microscopic and immunofluorescence studies.
    Lin AN; Smith LT; Fine JD
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):361-5. PubMed ID: 7615886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and very rare causative variants in the COL7A1 gene of Vietnamese patients with recessive dystrophic epidermolysis bullosa revealed by whole-exome sequencing.
    Ma THT; Luong TLA; Hoang TL; Nguyen TTH; Vu TH; Tran VK; Nguyen DB; Trieu TS; Nguyen HH; Nong VH; Nguyen DT
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1748. PubMed ID: 34286919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Woodley DT; Remington J; Chen M
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):78-84. PubMed ID: 18058258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser.
    Garza-Mayers AC; Su KA; Wiss K
    Pediatr Dermatol; 2022 Nov; 39(6):1005-1006. PubMed ID: 36063122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.
    Woodley DT; Keene DR; Atha T; Huang Y; Lipman K; Li W; Chen M
    Nat Med; 2004 Jul; 10(7):693-5. PubMed ID: 15195089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred.
    Yang CS; Lu Y; Farhi A; Nelson-Williams C; Kashgarian M; Glusac EJ; Lifton RP; Antaya RJ; Choate KA
    Pediatr Dermatol; 2012; 29(6):725-31. PubMed ID: 22515571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.